---
title: "SWATCH (SWGAY) Gets a Sell from Berenberg Bank"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289417524.md"
description: "Berenberg Bank analyst Nick Anderson CFA maintained a Sell rating on SWATCH (SWGAY) with an $8.20 price target, down from the closing price of $12.51. This aligns with the general Moderate Sell consensus and average price target for the stock."
datetime: "2026-06-11T06:00:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289417524.md)
  - [en](https://longbridge.com/en/news/289417524.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289417524.md)
generator: "portal-rs"
---

# SWATCH (SWGAY) Gets a Sell from Berenberg Bank

In a report released yesterday, Nick Anderson CFA from Berenberg Bank maintained a Sell rating on SWATCH, with a price target of $8.20. The company’s shares closed yesterday at $12.51.

### Introducing TipRanks MCP for Agents

-   Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools.
-   Designed for personal research, portfolio monitoring, and AI-assisted investment workflows.

According to TipRanks, Anderson CFA is a 2-star analyst with an average return of 0.4% and a 47.62% success rate.

The word on The Street in general, suggests a Moderate Sell analyst consensus rating for SWATCH with a $8.20 average price target.

### Related Stocks

- [SWGAY.US](https://longbridge.com/en/quote/SWGAY.US.md)
- [UHR.DE](https://longbridge.com/en/quote/UHR.DE.md)

## Related News & Research

- [Audemars Piguet and Swatch's new pocket watch collab has fans camping outside stores for days](https://longbridge.com/en/news/286457709.md)
- [Okta Unveils AI Agent Security Blueprint Alliance at Oktane](https://longbridge.com/en/news/299934497.md)
- [Google faces UK push to put AI assistants on Android, Chrome choice screens](https://longbridge.com/en/news/299872448.md)
- [Why Did SanDisk Stock Surge 6%? Rosenblatt Initiates With Buy as AI Storage Demand Keeps Heating Up](https://longbridge.com/en/news/299852158.md)
- [MRNA: Intismeran's phase III success and a diversified mRNA pipeline signal major growth ahead](https://longbridge.com/en/news/299918402.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**